Search
for
Sort by
Research 31–60 of 56
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset